Research ArticleTheranostics
Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P. Fendler, Rejah M. Alano, Sitaram S. Vangala, Amar U. Kishan, Nicholas Nickols, Matthew B. Rettig, Robert E. Reiter, Johannes Czernin and Jeremie Calais
Journal of Nuclear Medicine August 2020, 61 (8) 1153-1160; DOI: https://doi.org/10.2967/jnumed.119.237602
Ida Sonni
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Matthias Eiber
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
2Department of Nuclear Medicine, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
Wolfgang P. Fendler
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
3Department of Nuclear Medicine, University Hospital Essen, Essen, Germany
Rejah M. Alano
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
Sitaram S. Vangala
4Department of Medicine Statistics Core, UCLA, Los Angeles, California
Amar U. Kishan
5Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California
6Department of Urology, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
Nicholas Nickols
5Department of Radiation Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California
6Department of Urology, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
Matthew B. Rettig
6Department of Urology, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
8Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California
Robert E. Reiter
6Department of Urology, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
8Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California
Johannes Czernin
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
8Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California
Jeremie Calais
1Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, California
7Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California; and
8Institute of Urologic Oncology, David Geffen School of Medicine, UCLA, Los Angeles, California

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 8
August 1, 2020
Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P. Fendler, Rejah M. Alano, Sitaram S. Vangala, Amar U. Kishan, Nicholas Nickols, Matthew B. Rettig, Robert E. Reiter, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2020, 61 (8) 1153-1160; DOI: 10.2967/jnumed.119.237602
Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
Ida Sonni, Matthias Eiber, Wolfgang P. Fendler, Rejah M. Alano, Sitaram S. Vangala, Amar U. Kishan, Nicholas Nickols, Matthew B. Rettig, Robert E. Reiter, Johannes Czernin, Jeremie Calais
Journal of Nuclear Medicine Aug 2020, 61 (8) 1153-1160; DOI: 10.2967/jnumed.119.237602
Jump to section
Related Articles
Cited By...
- Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study
- Renal Cortical 68Ga-PSMA-11 PET and 99mTc-DMSA Images
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy